Profusa (PFSA) Total Current Liabilities (2021 - 2026)
Profusa's (PFSA) quarterly Total Current Liabilities came in at $29.0 million in Q1 2026, up 118.94% year-on-year from $13.3 million in Q1 2025, and up 30.38% quarter-over-quarter from $22.3 million in Q4 2025.
Profusa (PFSA) Total Current Liabilities (2021 - 2026) Analysis & Trends
Profusa's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $29.0 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 118.94% year-over-year to $29.0 million in Q1 2026; TTM through Mar 2026 was $29.0 million, a 118.94% increase from a year earlier, with the FY2025 full-year figure at $22.3 million, down 61.04% from the prior year.
- Total Current Liabilities rose to $29.0 million in Q1 2026 per PFSA's latest filing, from $22.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $57.1 million in Q4 2024 and bottomed at -$49000.0 in Q3 2025.
- The 5-year median for Total Current Liabilities is $4.0 million (2024), against an average of $9.8 million.
- Across the five-year window, Total Current Liabilities jumped 3001.07% in 2023 and slumped 100.95% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $935751.0 in 2022, then jumped by 425.94% to $4.9 million in 2023, then surged by 1060.81% to $57.1 million in 2024, then tumbled by 61.04% to $22.3 million in 2025, then surged by 30.38% to $29.0 million in 2026.
- Per Business Quant, the three latest PFSA Total Current Liabilities figures stand at $29.0 million (Q1 2026), $22.3 million (Q4 2025), and -$49000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Profusa | 77,314.98 | -297,685.02 | - | 29.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.02 Mn |
| Dec 31, 2025 | 22.26 Mn |
| Sep 30, 2025 | -49,000.00 |
| Jun 30, 2025 | 16.18 Mn |
| Mar 31, 2025 | 13.25 Mn |
| Dec 31, 2024 | 57.13 Mn |
| Sep 30, 2024 | 5.17 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 4.92 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 2.97 Mn |
| Mar 31, 2023 | 2.65 Mn |
| Dec 31, 2022 | 935,751.00 |
| Sep 30, 2022 | 400,282.00 |
| Jun 30, 2022 | 160,243.00 |
| Mar 31, 2022 | 85,588.00 |
| Dec 31, 2021 | 106,511.00 |